Crowdonomics
This isn’t Cytonics’s most recent raise. Reg CF Offering (2026) (Open) is more current.View latest round
Cytonics

Cytonics Corporation Preferred Stock 2

ClosedReached targetReg CFPreferred Equity
via SeedInvestView campaign
Raised
$2.8M / $5M max
57% of ceiling · target hit day 2
Investors
1,391
$2K avg
Post-money valuation
$61.8M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$2.8M$1.4M$0
1.4K6960
Apr 28, 2022 · openedOct 14, 2022 · last reading
Target ($25K) hit — Apr 30, 2022, day 2$1.0M raisedJun 18, 2022Deadline Oct 28, 2022 — 14 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via SeedInvest; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$365K
−$977K
FY2020
$308K
$2.5M
FY2021
RevenueNet income
Metric
FY2020
FY2021
Income statement
Revenue
$365,169
$307,500
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$976,922
$2,544,189
Taxes paid
$0
$0
Balance sheet
Cash
$537,592
$967,757
Accounts receivable
$18,417
$123,333
Total assets
$1,056,608
$1,756,758
Short-term debt
$157,633
$554,929
Long-term debt
$1,961,904
$0
Total liabilities
$2,119,537
$554,929
Other
Headcount
1
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$58.9M
Post-money$61.8M
Price / share$2.30
Shares offered10,870

Perks

Invest $15,000-$29,999, get complimentary consultation with a qualified physician, etc$15K+

Offering details

Target$25,000
Max$5,000,000
Min investment$1,001
OpenedApr 28, 2022
DeadlineOct 28, 2022
ClosedOct 14, 2022
Days active169

Links & provenance

Source: Manual
0001421744-22-000001

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.